Marino V, de la Lande I S, Newlyn M, Parker D A
Department of Dentistry, University of Adelaide, Australia.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Apr;347(4):371-8. doi: 10.1007/BF00165386.
The uptake and metabolism of 3H-noradrenaline has been examined in the FL cell-line derived originally from human amnion. Cell cultures metabolised 3H-noradrenaline (1.0 mumol/l) to 3H-normetanephrine and, to a lesser extent, to metabolites (not distinguished) of the O-methylated deaminated fraction; primary deaminated metabolites were not detected. 3H-normetanephrine formation a) was not saturable in the noradrenaline concentration range 0.2-150 mumol/l, b) was decreased to 20%-30% of control levels by uptake2 inhibitors (O-methylisoprenaline, 20 and 100 mumol/l; cimetidine, 10 mumol/l; hydrocortisone, 200 mumol/l) and c), was almost insensitive to uptake1 inhibitors (cocaine, 30 mumol/l; desipramine, 3 mumol/l). Uptake of noradrenaline was manifested after 30 minutes as a 6-fold increase in the cell content of the amine following inhibition of catechol-O-methyl transferase, either alone or in conjunction with inhibition of monoamine oxidase. Uptake was decreased maximally to 40% of control levels by O-methylisoprenaline. IC50 values for inhibition of the O-methylisoprenaline-sensitive component of uptake were (in mumol/l): corticosterone (0.3), papaverine (1.1), O-methylisoprenaline (3.0), cimetidine (6.0), (-)noradrenaline (460), and tetraethylammonium (2230). Except for the last agent, for which a comparative value is not available, the IC50's are in good agreement with those for inhibition of uptake2 in the Caki-1 cell-line reported by other investigators. The component of uptake resistant to O-methylisoprenaline was depressed by papaverine (a 50% decrease at 50 mumol/l), but was not affected by the other uptake2 inhibitors or by cocaine (30 mumol/l).(ABSTRACT TRUNCATED AT 250 WORDS)
在最初源自人羊膜的FL细胞系中研究了3H-去甲肾上腺素的摄取和代谢。细胞培养物将3H-去甲肾上腺素(1.0μmol/L)代谢为3H-间甲肾上腺素,并在较小程度上代谢为O-甲基化脱氨基部分的代谢产物(未区分);未检测到初级脱氨基代谢产物。3H-间甲肾上腺素的形成:a)在0.2 - 150μmol/L的去甲肾上腺素浓度范围内不饱和;b)被摄取2抑制剂(O-甲基异丙肾上腺素,20和100μmol/L;西咪替丁,10μmol/L;氢化可的松,200μmol/L)降低至对照水平的20% - 30%;c)对摄取1抑制剂(可卡因,30μmol/L;地昔帕明,3μmol/L)几乎不敏感。在抑制儿茶酚-O-甲基转移酶后30分钟,无论是单独抑制还是与单胺氧化酶抑制联合,去甲肾上腺素的摄取表现为细胞内胺含量增加6倍。O-甲基异丙肾上腺素可将摄取最大程度降低至对照水平的40%。抑制摄取的O-甲基异丙肾上腺素敏感成分的IC50值(以μmol/L计)为:皮质酮(0.3)、罂粟碱(1.1)、O-甲基异丙肾上腺素(3.0)、西咪替丁(6.0)、(-)去甲肾上腺素(460)和四乙铵(2230)。除最后一种药物(没有可用的比较值)外,IC50与其他研究者报道的Caki-1细胞系中摄取2抑制的IC50值高度一致。对O-甲基异丙肾上腺素耐药的摄取成分被罂粟碱抑制(50μmol/L时降低50%),但不受其他摄取2抑制剂或可卡因(30μmol/L)影响。(摘要截短于250字)